Agree your analysis, andrew. Somebody, likely Coliseum, is soaking up all sellers at 29c. I regarded the FY as a good report and expected more interest. No reason for holders to despair. Ash
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025